The Advanced Analysis Lab will collaborate with intelligence analysts and engineers from Lawrence Livermore National Laboratory to model processes that distinguish biowarfare substances from benign civilian pharmaceutical production. The proof of concept will be a suspect Iranian biowarfare facility.